Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates postincisional pain by regulating macrophage polarization

详细信息    查看全文

• 作者：Maiko Hasegawa-Moriyama ; Tetsuya Ohnou ; Kohei Godai ; Tae Kurimoto ; Mayo Nakama ; Yuichi Kanmura
• 关键词：Arg1 ; arginase-1 ; HO-1 ; heme oxygenase-1 ; IL ; interleukin ; ItgaX ; integrin ¦ÁX ; MIP2¦Á ; macrophage inflammatory protein 2¦Á ; NF-¦ÊB ; nuclear factor ¦ÊB ; PPAR¦Ã ; peroxisome proliferators-activated receptor ¦Ã
• 刊名：Biochemical and Biophysical Research Communications
• 出版年：2012
• 出版时间：14 September, 2012
• 年：2012
• 卷：426
• 期：1
• 页码：76-82
• 全文大小：520 K

文摘

Acute inflammation triggered by macrophage infiltration to injured tissue promotes wound repair and may induce pain hypersensitivity. Peroxisome proliferator-activated receptor ¦Ã (PPAR)¦Ã signaling is known to regulate heterogeneity of macrophages, which are often referred to as classically activated (M1) and alternatively activated (M2) macrophages. M1 macrophages have considerable antimicrobial activity and produce a wide variety of proinflammatory cytokines. In contrast, M2 macrophages are involved in anti-inflammatory and homeostatic functions linked to wound healing and tissue repair. Although it has been suggested that PPAR¦Ã agonists attenuate pain hypersensitivity, the molecular mechanism of macrophage-mediated effects of PPAR¦Ã signaling on pain development has not been explored. In this study, we investigated the link between the phenotype switching of macrophage polarization induced by PPAR¦Ã signaling and the development of acute pain hypersensitivity. Local administration of rosiglitazone significantly ameliorated hypersensitivity to heat and mechanical stimuli, and paw swelling. Consistent with the down-regulation of nuclear factor ¦ÊB (NF¦ÊB) phosphorylation by rosiglitazone at the incisional sites, the number of F4/80⁺iNOS⁺ M1 macrophages was decreased whereas numbers of F4/80⁺CD206⁺ M2 macrophages were increased in rosiglitazone-treated incisional sites 24 h after the procedure. In addition, gene induction of anti-inflammatory M2-macrophage-associated markers such as arginase1, FIZZ1 and interleukin (IL)-10 were significantly increased, whereas M1-macrophage-related molecules such as integrin ¦ÁX, IL-1¦Â, MIP2¦Á and leptin were decreased at rosiglitazone-treated incisional sites. Moreover, transplantation of rosiglitazone-treated peritoneal macrophages into the incisional sites significantly attenuated hyperalgesia. We speculate that local administration of rosiglitazone significantly alleviated the development of postincisional pain, possibly through regulating macrophage polarity at the inflamed site. PPAR¦Ã signaling in macrophages may be a potential therapeutic target for the treatment of acute pain development.